FOLD- Amicus Therapeutics, Inc.

Name: Amicus Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Campbell Bradley L	1.02M	$14.80M	-
Other	Rosenberg Ellen	464.6K	$6.73M	-
Other	Castelli Jeff	409.3K	$5.93M	-
Other	Clark David Michael	221.8K	$3.21M	-
CFO	Harford Simon N.R.	143.6K	$2.08M	-

Activity

Buys and sells only

Transactions

10 filings · page 7

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 3, 2023	Campbell Bradley L66	President &CEO	Sale+OE	11,700	$12.31	$144,016.47	-1.4%	-10.3%	-19.9%
Jun 15, 2023	Crowley John F67	Executive Chairman	Sell	6,044	$13.04	$78,813.76	-0.6%	+0.1%	-21.8%
Jun 6, 2023	Campbell Bradley L66	President &CEO	Sell	8,300	$12.50	$103,776.56	-1.0%	+1.1%	-16.2%
Jun 1, 2023	Campbell Bradley L66	President &CEO	Sale+OE	11,700	$11.36	$132,942.42	-1.4%	+15.5%	-14.0%
Jun 1, 2023	Crowley John F67	Executive Chairman	Sell	6,044	$11.36	$68,657.42	-0.6%	+15.5%	-14.0%
May 15, 2023	Crowley John F67	Executive Chairman	Sell	6,044	$11.18	$67,576.76	-0.6%	+18.7%	-16.7%
May 1, 2023	Crowley John F67	Executive Chairman	Sell	6,044	$11.80	$71,334.91	-0.6%	+14.5%	-16.1%
May 1, 2023	Campbell Bradley L66	President &CEO	Sale+OE	11,700	$11.80	$138,092.76	-1.4%	+14.5%	-16.1%
Apr 17, 2023	Crowley John F67	Executive Chairman	Sell	6,044	$11.66	$70,502.05	-0.6%	+12.5%	-11.0%
Apr 3, 2023	Campbell Bradley L66	President &CEO	Sale+OE	11,700	$11.21	$131,207.31	-1.4%	+9.1%	+1.0%

← PrevPage 7Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC